Q1 2021 Jazz Pharmaceuticals PLC Earnings Call Transcript
Welcome to the Jazz Pharmaceuticals plc First Quarter 2021 Earnings Conference Call. (Operator Instructions)
I will now turn the call over to Andrea Flynn, Head of Investor Relations to Jazz Pharmaceuticals. Thank you. Please go ahead.
Thank you, and good afternoon, everyone. Today, we reported our first quarter 2021 financial results. The press release and slide presentation accompanying this webcast are available on the Investors section of our website.
On the call today are Bruce Cozadd, Chairman and Chief Executive Officer; Renee Gala, Executive Vice President and Chief Financial Officer; Dan Swisher, President and Chief Operating Officer; and Rob Iannone, Executive Vice President, R&D and Chief Medical Officer. Joining the Q&A are Kim Sablich, Executive Vice President, General Manager of North America; Phil Jochelson, Neuroscience Therapeutic Head; and Anne Borgman, Hematology and Oncology Therapeutic Head.
On Slides 2 and 3, I'd like to remind you that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |